1. Alley, M. C., Scudiero, D. A. Monks, A., Hursey, M. L., Czerwinski, M. J., Fine, D. L., Abbott, B. J., Mayo, J. G., Shoemaker, R. H. and Boyd, M. R. 1988. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Research 48:589–601.
2. Bartus, H. R., Mirabelli, C. K., Auerbach, J. I., Shatzman, A. R., Taylor, D. P., Johnson, R. K., Rosenberg, M. and Crooke, S. T. 1984. Improved genetically modified Escherichia coli strain for prescreening antineoplastic agents. Antimicrobial Agents and Chemotherapy 25:622–625.
3. Bush, J. A., Long, B. H., Catino, J. J. and Bradner, W. T. 1987. Production and biological activity of rebeccamycin, a novel antitumor agent. Journal of Antibiotics (Tokyo) 40:668–678.
4. Cantino, J. J., Francher, D. M. and Schuring, J. E. 1986. Evaluation of cis-diammine-dichloroplatinum (II) combined with metoclopramide or sodium thiosulfate on L1210 leukemia in vitro and in vivo. Cancer Chemotherapy and Pharmacology 18:1–4.
5. Cantino, J. J., Francher, D. M., Edinger, K. J. and Stringfellow, D. A. 1985. A microtiter cytotoxicity assay useful for the discovery of fermentation-derived antitumor agents. Cancer Chemotherapy and Pharmacology 15:240–243.